The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I Study of Vinorelbine (V) and Capecitabine (C) in Advanced Breast Cancer (ABC).
 
Hiromichi Nakajima
No Relationships to Disclose
 
Naoko Inoshita
No Relationships to Disclose
 
Chihiro Kondoh
No Relationships to Disclose
 
Yukinori Ozaki
No Relationships to Disclose
 
Kenji Tomizawa
No Relationships to Disclose
 
Yutaka Hanaoka
No Relationships to Disclose
 
Shigeo Toda
No Relationships to Disclose
 
Yuko Tanabe
No Relationships to Disclose
 
Yuji Miura
No Relationships to Disclose
 
Jin Moriyama
No Relationships to Disclose
 
Shuichiro Matoba
No Relationships to Disclose
 
Hiroya Kuroyanagi
No Relationships to Disclose
 
Toshimi Takano
Honoraria - Daiichi Sankyo; Eisai; Kyowa Hakko Kirin
Research Funding - Chugai Pharma (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Puma Biotechnology (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)